GammaDelta Therapeutics is developing the potential of gamma delta (γδ) cells to create improved immunotherapy of cancer and other serious diseases. The company plans to exploit unique properties of tissue resident γδ T cells for effective immunotherapy.
This company has no teams yet
QuellTX
6 followers
The Health Foundation
2 followers
ORCHA
1 follower
Unobravo | Telehealth & psychology service
6 followers
Sutro Biopharma
3 followers
FUJIFILM Diosynth Biotechnologies
28 followers
Active Motif
3 followers
Altera Digital Health
3 followers
Abbott
432 followers
Merck
325 followers
Dyno Therapeutics
4 followers